Elsevier

Neuroscience Letters

Volume 410, Issue 1, 13 December 2006, Pages 1-5
Neuroscience Letters

Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence

https://doi.org/10.1016/j.neulet.2006.05.005Get rights and content

Abstract

The paper focuses on such candidate gene polymorphisms that alter alcoholism-related intermediate phenotypes including: dopaminergic system polymorphic variants (DRD2 -141C Ins/Del in promoter region, exon 8 and DRD2 TaqI A and DAT 40bp VNTR genes polymorphisms) that cause predisposition to severe alcoholism (haplotype Ins/G/A2); COMT Val158Met gene polymorphism related to differences in executive cognitive function and 5-HTT gene promoter polymorphism, which alters stress response and affects anxiety and dysphoria. The transmission disequilibrium test (TDT) was used in the study. One hundred Polish families with alcohol dependence were recruited. The control subjects for the case-control study were 196 ethnically and gender matched healthy individuals. It was found that DRD2 TaqIA and DAT gene polymorphisms contained statistically significant differences in allele transmission. In the homogenous subgroups of patients with early onset and with withdrawal complications a statistically significant preferential A2 allele transmission was found in DRD2 TaqIA gene polymorphism. The alleles and genotypes distribution of the investigated polymorphisms did not differ significantly between the alcoholics and the controls in the case-control study. The results confirmed the fact that the candidate genes (DRD2 and DAT) are partially responsible for the development of alcohol dependence. The results are also in agreement with the hypothesis that there are various subtypes of alcohol dependence, which differ depending on their genetic background. Meanwhile, the currently available pharmacological therapies for alcoholism treatment are effective in some alcoholics but not for all of them. Some progress has been made in elucidating pharmacogenomic responses to drugs, particularly in the context of Clonninger and Lesch typology classification system for alcoholics.

Section snippets

Acknowledgments

This work was supported by KBN: 3 PO5D14622 and BMBF, POL 01/063.

References (46)

  • U. Finckh et al.

    Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism

    Pharmacogenetics

    (1997)
  • P.F. Foley et al.

    Association studies of neurotransmitter gene polymorphisms in alcoholic Caucasians

    Ann. N.Y. Acad. Sci.

    (2004)
  • T. Geijer et al.

    Dopamine D2-receptor gene polymorphisms in Scandinavian chronic alcoholics

    Eur. Arch. Psychiatry Clin. Neurosci.

    (1994)
  • D. Goldman et al.

    COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms

    J. Stud. Alcohol. Suppl.

    (2005)
  • T. Hallikainen et al.

    Ethanol consumption and DRD2 gene TaqI a polymorphism among socially drinking males

    Am. J. Med. Genet. A

    (2003)
  • A. Heils et al.

    Allelic variation of human serotonin transporter gene expression

    J. Neurochem.

    (1996)
  • A. Heinz et al.

    Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence

    Psychopharmacology (Berl)

    (2004)
  • K. Kidd et al.

    A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus

    Hum. Genet.

    (1998)
  • K. Kidd et al.

    DRD2 haplotypes containing the TaqI A1 allele: implications for alcoholism research

    Alcoholism: Clin. Exp. Res.

    (1996)
  • M.D. Kohnke et al.

    Plasma homovanillic acid: a significant association with alcoholism is independent of a functional polymorphism of the human catechol-O-methyltransferase gene

    Neuropsychopharmacology

    (2003)
  • T. Konishi et al.

    ADH1B*1, ADH1C*2, DRD2 (-141C Ins), and 5-HTTLPR are associated with alcoholism in Mexican American men living in Los Angeles

    Alcohol. Clin. Exp. Res.

    (2004)
  • H.M. Lachman et al.

    Human catechol-O-methyltranferase pharmacogenetics: description of functional polymorphism and its potential application to neuropsychiatric disorders

    Pharmacogenetics

    (1996)
  • T.P. Laine et al.

    The A1 allele of the D2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics

    Alcohol Alcohol.

    (2001)
  • Cited by (0)

    View full text